BOSTON--(BUSINESS WIRE)--Verastem, Inc., a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced today the appointment of Jonathan Pachter, Ph.D., as Vice President and Head of Research.
